Shop local San Diego stores and makers

Compare nearby shops and deals

The shopping search helps you discover local stores, compare availability, find makers and farmers markets, and locate specialty shops near you. Search by neighborhood, product, price range, or seller type to find what you need locally.

Latest Shopping News

BIOENGINEER.ORG
bioengineer.org > epigenetic-age-tests-face-expert-backlash-over-reliability-privacy-and-ageism

Epigenetic Age Tests Face Expert Backlash Over Reliability, Privacy and

3+ hour, 36+ min ago   (68+ words) Aging has become a product. Across North America and Europe, companies now sell direct-to-consumer epigenetic tests that estimate a customer’s biological age from DNA methylation patterns, often bundled with supplements and lifestyle programs marketed as capable of slowing or even…...

PharmExec
pharmexec.com > view > boards-ai-500-years-experience-life-sciences-takeaways-board-forum

Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum

5+ hour, 11+ min ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

Hoodline
hoodline.com > 2026 > 09 > palo-alto-s-frazier-life-sciences-piles-1-1b-into-public-biotech-fund

Frazier Life Sciences Raises $1.1B for Public Fund

10+ hour, 31+ min ago   (202+ words) Frazier Life Sciences has closed more than $1.1 billion in new capital commitments to its Public Fund, pushing the long-only investment vehicle's total committed capital to roughly $2.8 billion. The Palo Alto-based firm announced the raise Thursday, marking one of the largest…...

BIOENGINEER.ORG
bioengineer.org > silencing-scamp3-eases-hypoxic-pulmonary-hypertension-by-engaging-the-ubiquitin-ligase-wwp1

Silencing SCAMP3 Eases Hypoxic Pulmonary Hypertension by Engaging the

14+ hour, 53+ min ago   (610+ words) Pulmonary hypertension remains one of the most stubborn challenges in cardiovascular medicine, and a new study now points to an unexpected molecular player in the disease process....

Yahoo Finance
finance.yahoo.com > healthcare > articles > karyopharm-pushes-off-debt-payment-093700095.html

Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use

1+ day, 18+ hour ago   (321+ words) Karyopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup banked $275 million....

The Tiger's Roar
tigersroar.com > online_features > press_releases > article_3d8b812a-af85-5999-9a60-6dfb004cbfc7.html

Biotech Startups Qualify for R&D Tax Credits More Often Than They Realize, K-38 Consulting Reports

1+ day, 6+ hour ago   (86+ words) ...

Yahoo Finance
finance.yahoo.com > technology > ai > articles > agilisium-receives-frost-sullivans-2026-140000595.html

Agilisium Receives Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition for Agentic AI in Life Sciences

4+ day, 52+ min ago   (811+ words) Moving artificial intelligence from experimentation into meaningful, production-scale applications is becoming increasingly important as life sciences organizations manage complex data, stringent regulations, and growing pressure to accelerate decision-making. Agilisium is helping address this need through a domain-oriented approach to agentic…...

ScienceDaily
sciencedaily.com > releases > 2025 > 04 > 250416135234.htm

Supercharged mitochondria spark aging-related blood disorders

1+ day, 19+ hour ago   (487+ words) As we age, blood stem cells, the essential source of new blood cells in the body, can accumulate genetic mutations. These mutations can give the cells a growth advantage, laying the foundation for developing serious health conditions. Now, scientists at…...

BioPharma Dive
biopharmadive.com > news > moonwalk-series-b-obesity-rna-interference > 829784

Moonwalk reloads with $70M and new RNAi prospects for obesity

5+ day, 3+ hour ago   (331+ words) The California biotech plans to bring its first drug, enabled by licensing technology from a Chinese drugmaker, into clinical testing for obesity by the end of 2027. When Moonwalk Biosciences launched in 2024, it set ambitious plans to mine the epigenome for…...